Association between rubella vaccination response and long-term immune response to severe acute respiratory syndrome coronavirus 2 after BNT162b2 vaccination.

Publication date: Aug 31, 2023

In a previous study, we demonstrated an association between a low response to rubella vaccination and a decreased acquisition of anti-severe acute respiratory syndrome coronavirus 2 spike immunoglobulin G (anti-S IgG) shortly after the second dose of the BNT162b2 vaccine. The present study aimed to explore whether this association persists in terms of long-term antibody retention following the second dose of BNT162b2. Through multivariable analysis, we found a significant association between a low response to rubella vaccination and reduced anti-S IgG titers approximately eight months after the second dose of BNT162b2.

Concepts Keywords
Bnt162b2 Antibody
Coronavirus BNT162b2
Low COVID-19
Rubella Rubella
Vaccination SARS-CoV-2
Vaccine

Semantics

Type Source Name
disease MESH rubella
disease VO vaccination
disease IDO immune response
disease VO Severe acute respiratory syndrome coronavirus 2
disease VO dose
disease VO vaccine
disease MESH COVID-19

Original Article

(Visited 1 times, 1 visits today)